2016 Epilepsy Treatment 
FloridaMarijuana.net
JUNE 12, 2018
The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary.
Cannabis Law Report
JANUARY 15, 2019
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MGC Pharma
FEBRUARY 15, 2018
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.
Veriheal
FEBRUARY 24, 2021
In June of 2016, the UK voted in favor of a departure from the European Union. Unfortunately, this had a powerful impact on a small subset of residents—UK children suffering from epilepsy who had been dependent on imported medications to help control their illness. Thanks to Brexit, UK Children With Epilepsy Have Little if Any Options.
Canna Law Blog
MARCH 12, 2019
9,066,920 – “Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy” (“the 920 Patent”). Epidiolex was approved to treat two rare forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. In this case, the subject patent was U.S. GW Pharma”) and Otsuka Pharmaceuticals Co.,
Alchimia
JUNE 20, 2016
The exact CBD dosage still remains undefined by the science and greatly varies depending on the disease to treat; most treatments start with a dose of 1mg CBD per Kg of bodyweight, which is gradually increased if necessary. That could explain why kids using CBD to treat epilepsy may experience some of the side effects of THC, like sleepiness.
Canna Law Blog
MARCH 7, 2019
In 2016, the FDA expanded its regulatory authority to all products meeting the TCA’s statutory definition of a tobacco product, such as e-cigarettes, cigars, pipes and waterpipes. Yet, as of the date of this post, the FDA has only approved CBD as a pharmaceutical drug in the treatment of epilepsy ( Epidiolex ).
Expert insights. Personalized for you.
187 
Let's personalize your content